Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy D Shapiro

Showing results (1-10 of 76) with videos related to

Pageof 8
Sort By:
Hematology. American Society of Hematology. Education Program|December 10, 2013
Long-lasting recombinant factor VIII proteins for hemophilia AAmy D Shapiro
Vascular Health and Risk Management|December 15, 2007
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia AAmy D Shapiro
Clinical Advances in Hematology & Oncology : H&O|September 30, 2008
Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitorsAmy D Shapiro
Blood Advances|February 11, 2021
Concizumab: a novel anti-TFPI therapeutic for hemophiliaAmy D Shapiro
F1000Research|August 22, 2019
Merging into the mainstream: the evolution of the role of point-of-care musculoskeletal ultrasound in hemophiliaNihal Bakeer, Amy D Shapiro
Therapeutic Advances in Drug Safety|August 2, 2014
Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomesAmy D Shapiro, Ulla Hedner
Lancet (London, England)|March 30, 2012
Modern haemophilia careErik Berntorp, Amy D Shapiro
Blood|March 16, 2025
How I treat type 1 plasminogen deficiencyAmy D Shapiro, Charles Nakar
Journal of Blood Medicine|February 25, 2025
Emerging Therapies in Hemophilia: Improving Equitable Access to CareMagdalena Lewandowska, Sonia Nasr, Amy D Shapiro
Blood|February 26, 2015
Rare bleeding disorders: diagnosis and treatmentRoberta Palla, Flora Peyvandi, Amy D Shapiro
Pageof 8

Showing results (1-10 of 76) with videos related to

Sort By:
Pageof 8
Hematology. American Society of Hematology. Education Program|December 10, 2013
Long-lasting recombinant factor VIII proteins for hemophilia AAmy D Shapiro
Vascular Health and Risk Management|December 15, 2007
Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE) in the management of hemophilia AAmy D Shapiro
Clinical Advances in Hematology & Oncology : H&O|September 30, 2008
Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitorsAmy D Shapiro
Blood Advances|February 11, 2021
Concizumab: a novel anti-TFPI therapeutic for hemophiliaAmy D Shapiro
F1000Research|August 22, 2019
Merging into the mainstream: the evolution of the role of point-of-care musculoskeletal ultrasound in hemophiliaNihal Bakeer, Amy D Shapiro
Therapeutic Advances in Drug Safety|August 2, 2014
Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomesAmy D Shapiro, Ulla Hedner
Lancet (London, England)|March 30, 2012
Modern haemophilia careErik Berntorp, Amy D Shapiro
Blood|March 16, 2025
How I treat type 1 plasminogen deficiencyAmy D Shapiro, Charles Nakar
Journal of Blood Medicine|February 25, 2025
Emerging Therapies in Hemophilia: Improving Equitable Access to CareMagdalena Lewandowska, Sonia Nasr, Amy D Shapiro
Blood|February 26, 2015
Rare bleeding disorders: diagnosis and treatmentRoberta Palla, Flora Peyvandi, Amy D Shapiro
Pageof 8